Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance

Bibliografski detalji
Glavni autori:	Xu, S, Scott, C, Coleman, RL, Tuomilehto, J, Holman, RR
Format:	Conference item
Jezik:	English
Izdano:	Springer Nature 2019

Slični predmeti

Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
od: Xu, S, i dr.
Izdano: (2021)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
od: Wamil, M, i dr.
Izdano: (2020)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
od: Leal, J, i dr.
Izdano: (2022)

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
od: Holman, R, i dr.
Izdano: (2017)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
od: Currie, G, i dr.
Izdano: (2017)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
od: Wamil, M, i dr.
Izdano: (2020)

Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial
od: Liam Mc Morrow, i dr.
Izdano: (2024-02-01)

Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
od: Nihar Ranjan Mohanty, i dr.
Izdano: (2022-06-01)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
od: Wamil, M, i dr.
Izdano: (2021)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
od: Califf, R, i dr.
Izdano: (2003)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
od: Califf, R, i dr.
Izdano: (2008)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
od: Anke Tönjes, i dr.
Izdano: (2010-01-01)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
od: Yates, T, i dr.
Izdano: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
od: Yates, T, i dr.
Izdano: (2014)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
od: Gerstein, H, i dr.
Izdano: (2006)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
od: Stevens, R, i dr.
Izdano: (2005)

Perceived Symptoms in People Living with Impaired Glucose Tolerance
od: Susanne Andersson, i dr.
Izdano: (2011-01-01)

Florid diabetic complications in impaired glucose tolerance
od: Anil P Bhatt, i dr.
Izdano: (2013-01-01)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
od: Farrer, M, i dr.
Izdano: (1993)

Oxidative injury and neuropathy in diabetes and impaired glucose tolerance
od: James W. Russell, i dr.
Izdano: (2008-06-01)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
od: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
Izdano: (2012-01-01)

Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.
od: Holman, R, i dr.
Izdano: (1979)

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
od: Preiss, D, i dr.
Izdano: (2013)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
od: Mostafa, SA, i dr.
Izdano: (2017)

FASTING BLOOD-GLUCOSE CONCENTRATIONS AND TREATMENT OF MATURITY-ONSET DIABETES
od: Howedavies, S, i dr.
Izdano: (1980)

Effect of Apple Consumption on Postprandial Blood Glucose Levels in Normal Glucose Tolerance People versus Those with Impaired Glucose Tolerance
od: Yutaka Inoue, i dr.
Izdano: (2022-06-01)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
od: Holman, R
Izdano: (1996)

Identification of Significant Predictors for the Need of Insulin Therapy and Onset of Postpartum Impaired Glucose Tolerance in Gestational Diabetes Mellitus Patients
od: Wang T, i dr.
Izdano: (2021-06-01)

Comparison of in vivo tests for glucose tolerance in subjects with normal, impaired glucose tolerance and type 2 diabetes
od: Hermans, M, i dr.
Izdano: (1996)

New-onset diabetes after transplantation and oral glucose tolerance test
od: Somsri Wiwanitkit, i dr.
Izdano: (2014-01-01)

The basal plasma glucose: a simple relevant index of maturity-onset diabetes.
od: Holman, R, i dr.
Izdano: (1981)

CONTROL OF MATURITY-ONSET DIABETES BY HOME OR CLINIC MONITORING OF FASTING PLASMA GLUCOSE
od: Howedavies, S, i dr.
Izdano: (1978)

Predicting post one-year durability of glucose-lowering monotherapies in patients with new-onset type 2 diabetes
od: Agbaje, O, i dr.
Izdano: (2017)

Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study
od: Xin Zhang, i dr.
Izdano: (2023-01-01)

Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
od: Ursula Mager, i dr.
Izdano: (2008-08-01)

Dyslipidemia, metabolic syndrome, and liver enzymes in impaired glucose tolerance and new onset untreated, type 2 diabetes Indian subjects
od: Debmalaya Sanyal, i dr.
Izdano: (2012-01-01)

Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes.
od: McLellan, J, i dr.
Izdano: (1995)

Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model
od: Coleman, RL, i dr.
Izdano: (2019)

Machine learning-based models to predict one-year mortality among Chinese older patients with coronary artery disease combined with impaired glucose tolerance or diabetes mellitus
od: Yan Li, i dr.
Izdano: (2023-06-01)

Association Between Onset of Type 2 Diabetes and Risk of Atrial Fibrillation in New Zealanders With Impaired Glucose Tolerance Over 25 Years
od: Dahai Yu, i dr.
Izdano: (2023-09-01)